PNC Financial Services Group
ENZ

PNC Financial Services Group’s Enzo Biochem, Inc. ENZ Stock Holding History

PNC Financial Services Group’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-700
Closed -$259 – 5120
2025
Q1 		$259 Hold
700
– – ﹤0.01% 4744
2024
Q4 		$500 Buy
+700
New +$725 ﹤0.01% 4529
2018
Q4 		– Sell
-183
Closed -$1K – 4200
2018
Q3 		$1K Sell
183
-1,817
-91% -$8.25K ﹤0.01% 4068
2018
Q2 		$10K Buy
+2,000
New +$12.2K ﹤0.01% 3694
2013
Q3 		– Sell
-249
Closed -$1K – 3667
2013
Q2 		$1K Buy
+249
New +$550 ﹤0.01% 3467

Other funds holding ENZ

OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

PNC Financial Services Group's ENZ Position: Q2 2025 in Review

PNC Financial Services Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 700 shares — an estimated $259 sold.

PNC Financial Services Group first reported a position in ENZ in Q2 2013 and held it in 5 quarters. The position peaked at $10K in Q2 2018. 7 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • PNC Financial Services Group reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 700 Enzo Biochem, Inc. shares in Q2 2025, an estimated $259.
  • PNC Financial Services Group first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 5 quarters.
  • PNC Financial Services Group's Enzo Biochem, Inc. position peaked at $10K in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.